We invite you to apply for this year’s EHA Topics-in-Focus Preceptorship on Hemoglobinopathies: From Diagnosis and Prevention to Personalized Management and Cure.
Apply for a travel grant and take part in this unique opportunity to deepen your knowledge through expert-led lectures, real case discussions, and practical workshops.
Travel grants include registration and accommodation, plus up to €1,000 in travel support.
With only 26 spots available, early application is encouraged! Apply by June 26, 2026: https://t.co/2CLLEENOcR
Our Opening Panel at the “All-Island Cancer Summit” explored priorities needed to strengthen cancer care;
✔️Fund/deliver National Cancer Strategy
✔️ Ring-fence investment for infrastructure, capacity & access to medicines
✔️ Improve transparency by collecting/publishing data
Celebrating #ECND26SupportingLifeBeyondCancer@stjamesdublin@CancerInstIRE 💫 Supporting life beyond cancer, nurses play a vital role throughout survivourship and long term followup. We strive to provide the highest quality cancer nurse practice, research and education #ECND26
🔊 Out now: Tune into the latest episode of the Blood Matters podcast for Nurses 🎙️ Patient Safety Matters
This time, @Hilda39113610@EmmaNurseTutor are joined by Elin Öfverberg to discuss patient safety in HCT and cellular therapies. Watch on YouTube ➡️ https://t.co/9bfBcl41Gf
The countdown is on for the 2026 Cancer Retreat.
A morning of discussion, collaboration and future-focused conversations on strengthening cancer trials in Ireland.
📅 Friday, 22 May
📍 RCSI, Dublin
🕘 09:00–13:15 + networking lunch
See you there? Register now: https://t.co/I73MA1h6cm
Super excited to share our How-I-Treat our today in @BloodPortfolio where we show how we integrate somatic mutations and other alterations 🧬 into the diagnosis and clinical care of #BMFsm patients. @fergutierrezro1@bhavishap29@NIH https://t.co/CnSeDfvc7E
A great session on predisposition to myeloid malignancy at the @UTMDAnderson#MDS symposium! Lucy Godley @NorthwesternU gave the keynote opening talk showing the high incidence of germline predisposition in #MDS patients. 1/7
We’re delighted to share that Trinity St James’s Cancer Institute has been awarded the INTERACT EUROPE 100 Silver Badge, recognising our commitment to multidisciplinary collaboration, education and excellence in cancer care. #INTERACTEurope#CancerCare
https://t.co/PguOkEDJsr
A special evening in Dining Hall at @tcddublin celebrating excellence in cancer research.
Prof. @CharlesSwanton - 2026 Recipient of the Burkitt Medal - a true clinician-scientist & pioneer behind ‘TRACERx’ @TheCrick - Congrats!🏅👏🏼
The #BurkittMedal is awarded by @CancerInstIRE
We’re delighted to see @CancerInstIRE Research Director, Prof Lorraine O’Driscoll as she opens the #Cancerconference, setting the stage for a powerful programme focused on innovation, collaboration and impact in cancer research and care #CancerResearch
We are delighted to announce a session on Young Onset Cancers open for patient/ public attendance for our upcoming TSJCI International Cancer Conference from 8.30-10.00am on the 15th April in TCD. Attendance is free but please register below ⬇️
https://t.co/5tkwWm1j2U
Countdown to the TSJCI International Cancer Conference ‘Transforming Cancer Research and Care’ April 14-15. Join us on April 14th to hear from our 2026 Burkitt Award winner, Prof Charles Swanton. https://t.co/mYJ0926bDV
Your research depends on access to the right support. Share your insights in the EHA Community Survey and help shape what comes next for research funding, training, and opportunities in hematology, in just 10 minutes.
Complete the survey for a chance to win a complimentary #EHA2026 registration: https://t.co/M1wnSssCyF
Dr Sarah Kelliher presenting her work on survival outcomes following allogeneic HSCT for TP53 myeloid malignancies in Madrid at EBMT 2026. Well done Sarah! @CancerInstIRE@stjamesdublin@DurkanLab